Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Q3VE
|
||||
Former ID |
DIB015542
|
||||
Drug Name |
PF-04971729
|
||||
Synonyms |
PF-4971729; SGLT2 inhibitor (oral, type 2 diabetes), Pfizer; Sodium glucose cotransporter-2 inhibitor (oral, type 2 diabetes), Pfizer
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Phase 3 | [524892] | ||
Company |
Merck; pfizer
|
||||
Structure |
Download2D MOL |
||||
Formula |
C22H25ClO7
|
||||
InChI |
InChI=1S/C22H25ClO7/c1-2-28-16-6-3-13(4-7-16)9-14-10-15(5-8-17(14)23)22-20(27)18(25)19(26)21(11-24,30-22)12-29-22/h3-8,10,18-20,24-27H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22-/m0/s1
|
||||
InChIKey |
MCIACXAZCBVDEE-CUUWFGFTSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | SLGT2 | Target Info | Modulator | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.